Daily briefing: Are gut bacteria causing eye diseases?

Katrina Krämer

DOI: https://doi.org/10.1038/d41586-024-00605-8

IF: 64.8

2024-02-27

Nature

Abstract:Experiments in mice suggest that some eye diseases might be caused in part by escapee bacteria. Plus, giant ‘bubble’ in space could be source of powerful cosmic rays and why live music makes us more emotional than recordings.

multidisciplinary sciences

What problem does this paper attempt to address?

Gut Microbes and Eye Disease

Patrick Donabedian,Elizabeth Dawson,Qiuhong Li,Jinghua Chen

DOI: https://doi.org/10.1159/000519457

2021-12-16

Ophthalmic Research

Abstract:Microbial symbionts in the gut are increasingly recognized as having important effects on health and disease, but have only recently begun to be linked to diseases of the eye. We review current research on the intestinal microbiota’s relationship to ocular disease, focusing on autoimmune uveitis, diabetic retinopathy, age-related macular degeneration, and primary-open angle glaucoma. We discuss findings and limitations of this exciting new area of ophthalmology research and explore possible future disease-modifying treatments.

ophthalmology
The surprising link between gut bacteria and devastating eye diseases

Saima Sidik

DOI: https://doi.org/10.1038/d41586-024-00562-2

IF: 64.8

2024-02-27

Nature

Abstract:Finding raises hopes that antibiotics could treat some genetic diseases that can cause blindness — but also prompts doubts. Finding raises hopes that antibiotics could treat some genetic diseases that can cause blindness — but also prompts doubts.

multidisciplinary sciences
Gut microbiota and eye diseases: A review

Yue Zhao,Peijin Qiu,Ting Shen

DOI: https://doi.org/10.1097/md.0000000000039866

IF: 1.6

2024-09-29

Medicine

Abstract:The human body harbors numerous bacteria, all of which significantly impact our overall health. [ 1 ] Among these, gut microbes are particularly vital. [ 2 ] These microbes are heterogeneous and vary across individuals. The intestinal microbiota is a dynamic system that begins forming early in life and is easily influenced by external factors such as environment, diet, and lifestyle, eventually stabilizing in adulthood. [ 3 ] It plays a crucial role in maintaining the integrity of the intestinal barrier, influencing host nutrient metabolism, participating in immune regulation, and combating pathogens. [ 4 , 5 ] The intestinal microbiota consists of bacteria, fungi, archaea, viruses, and other microorganisms, with bacteria being the most predominant. [ 6 ] At the phylum level, Bacteroidetes, Actinomycetes, Firmicutes, and Proteobacteria are the most prevalent. [ 7 ] When the gut microbiota is dysbiotic, its diversity and abundance diminish, leading to impaired physiological functions and affecting extraintestinal organs such as the nervous and immune systems. [ 8 , 9 ] The gut microbiota is closely linked to systemic diseases, influencing their onset and progression. Increasing evidence suggests that gut microbiome dysregulation is associated with ocular diseases, including diabetic retinal disease, age-related macular degeneration, glaucoma, and autoimmune uveitis. [ 10–12 ] The primary aim of this review is to elucidate the relationship between gut microbiota and ocular diseases and to propose potential therapeutic strategies, offering new insights for the prevention and treatment of eye diseases.

medicine, general & internal
The Gut-Eye Axis: Lessons Learned from Murine Models

Jason L Floyd,Maria B Grant

DOI: https://doi.org/10.1007/s40123-020-00278-2

Abstract:A healthy gut microbiota is essential in maintaining the human body in a homeostatic state by its functions in digestion and immune tolerance. Under states of aberrant microbial composition or function (dysbiosis), the gut microbiota induces systemic inflammation that can lead to the onset of many diseases. In this review, we describe some evidence, largely from rodent studies, that supports the possible role of a dysbiotic gut microbiota in the onset and exacerbation of ocular diseases, primarily diabetic retinopathy, age-related macular degeneration, choroidal neovascularization, and uveitis. Furthermore, we examine several potential therapeutic measures that show promise in restoring the gut microbiota to a eubiotic state, preventing the aforementioned disease pathologies.
Daily briefing: New evidence supports controversial hypothesis of ‘transmissible’ Alzheimer’s

Katrina Krämer

DOI: https://doi.org/10.1038/d41586-024-00282-7

IF: 64.8

2024-01-30

Nature

Abstract:A small study seems to suggest that proteins related to the neurodegenerative disease can be transferred from person to person through surgical procedures. Plus, Japan’s Moon lander makes a comeback and ‘wildly weird’ scraps of genetic material discovered in gut microbes.

multidisciplinary sciences
We are not alone: a case for the human microbiome in extra intestinal diseases

S Shivaji

DOI: https://doi.org/10.1186/s13099-017-0163-3

2017-03-07

Abstract:Background: "Dysbiosis" in the gut microbiome has been implicated in auto-immune diseases, in inflammatory diseases, in some cancers and mental disorders. The challenge is to unravel the cellular and molecular basis of dysbiosis so as to understand the disease manifestation. Main body: Next generation sequencing and genome enabled technologies have led to the establishment of the composition of gut microbiomes and established that "dysbiosis" is the cause of several diseases. In a few cases the cellular and molecular changes accompanying dysbiosis have been investigated and correlated with the disease. Gut microbiome studies have indicated that Christensenella minuta controls obesity in mice, Faecalibacterium prausnitzii protects mice against intestinal inflammation and Akkermansia muciniphila reverses obesity and insulin resistance by secreting endocannabinoids. In mice polysaccharide antigen A on the surface of Bacteroides fragilis, reduces inflammation. Such experiments provide the link between the gut microbiome and human health but implicating dysbiosis with extra-intestinal diseases like arthritis, muscular dystrophy, vaginosis, fibromyalgia, some cancers and mental disorders appears to be more challenging. The relevance of gut microbiome to the eye appears to be very remote. But considering that the eye is the site of inflammatory diseases like uveitis, scleritis, Mooren's corneal ulcer etc. it is possible that these diseases are also influenced by dysbiosis. In mice signals from the gut microbiota activate retina specific T cells that are involved in autoimmune uveitis. Such information would open up new strategies for therapy where the emphasis would be on restoring the diversity in the gut by antibiotic or specific drug use, specific microbe introduction, probiotic use and fecal transplant therapy. The ocular surface microbiome may also be responsible for eye diseases in man but such studies are lacking. Microbiome of the healthy cornea and conjunctiva have been identified. But whether the ocular microbiome exhibits dysbiosis with disease? Whether ocular microbiome is influenced by the gut microbiome? What mediates the cross-talk between the gut and ocular microbiomes? These are questions that need to be addressed to understand idiopathic infections of the eye. Conclusions: Evaluating diseases remote from the gut would unfold the mysteries of the microbiome.
How gut microbiota may impact ocular surface homeostasis and related disorders

Marc Labetoulle,Christophe Baudouin,Jose M. Benitez del Castillo,Maurizio Rolando,Maria Rescigno,Elisabeth M. Messmer,Pasquale Aragona

DOI: https://doi.org/10.1016/j.preteyeres.2024.101250

IF: 19.704

2024-03-09

Progress in Retinal and Eye Research

Abstract:Changes in the bacterial flora in the gut, also described as gut microbiota, are readily acknowledged to be associated with several systemic diseases, especially those with an inflammatory, neuronal, psychological or hormonal factor involved in the pathogenesis and/or the perception of the disease. Maintaining ocular surface homeostasis is also based on all these four factors, and there is accumulating evidence in the literature on the relationship between gut microbiota and ocular surface diseases. The mechanisms involved are mostly interconnected due to the interaction of central and peripheral neuronal networks, inflammatory effectors and the hormonal system. A better understanding of the influence of the gut microbiota on the maintenance of ocular surface homeostasis, and on the onset or persistence of ocular surface disorders could bring new insights and help elucidate the epidemiology and pathology of ocular surface dynamics in health and disease. Revealing the exact nature of these associations could be of paramount importance for developing a holistic approach using highly promising new therapeutic strategies targeting ocular surface diseases.

ophthalmology
The gut microbiota in retinal diseases

Marie-Agnès Bringer,Pierre-Henry Gabrielle,Alain M Bron,Catherine Creuzot-Garcher,Niyazi Acar

DOI: https://doi.org/10.1016/j.exer.2021.108867

Abstract:The gut microbiota is a complex ecosystem that inhabits the gastrointestinal tract and consists of archaea, fungi, viruses, and bacteria, with bacteria being dominant. From birth onwards, it coevolves dynamically together with the host. The composition of the gut microbiota is under the influence of a complex interplay between both host and environmental factors. Scientific advances in the past few decades have shown that it is essential in maintaining homeostasis and tipping the balance between health and disease. In addition to its role in food digestion, the gut microbiota is implicated in regulating multiple physiological processes in the host gut mucosa and in distant organs such as the brain. Persistent imbalance between gut microbial communities, termed "dysbiosis," has been associated with several inflammatory and metabolic diseases as well as with central nervous system disorders. In this review, we present the state of the art of current knowledge on an emerging concept, the microbiota-retina axis, and the potential role of its disturbance in the development of retinopathies. We also describe several microbiota-targeting strategies that could constitute preventive and therapeutic tools for retinopathies.
Microbiome and Retinal Vascular Diseases

Joel-Benjamin Lincke,Lucine Christe,Jan Darius Unterlauft,Martin S Zinkernagel,Denise C Zysset-Burri

DOI: https://doi.org/10.1016/j.ajpath.2023.02.017

Abstract:The gut microbiome consists of more than a thousand different microbes and their associated genes and microbial metabolites. It influences various host metabolic pathways and is therefore important for homeostasis. In recent years, its influence on health and disease has been extensively researched. Dysbiosis, or imbalance in the gut microbiome, is associated with several diseases. Consequent chronic inflammation may lead to or promote inflammatory bowel disease, obesity, diabetes mellitus, atherosclerosis, alcoholic and non-alcoholic liver disease, cirrhosis, hepatocellular carcinoma, and other diseases. The pathogenesis of the three most common retinal vascular diseases, diabetic retinopathy, retinal vein occlusion, and retinal artery occlusion, may also be influenced by an altered microbiome and associated risk factors such as diabetes mellitus, atherosclerosis, hypertension, and obesity. Direct cause-effect relationships remain less well understood. A potential prevention or treatment modality for these diseases could be targeting and modulating the individual's gut microbiome.
Targeting the Gut-Eye Axis: An Emerging Strategy to Face Ocular Diseases

Lucrezia Irene Maria Campagnoli,Angelica Varesi,Annalisa Barbieri,Nicoletta Marchesi,Alessia Pascale

DOI: https://doi.org/10.3390/ijms241713338

2023-08-28

Abstract:The human microbiota refers to a large variety of microorganisms (bacteria, viruses, and fungi) that live in different human body sites, including the gut, oral cavity, skin, and eyes. In particular, the presence of an ocular surface microbiota with a crucial role in maintaining ocular surface homeostasis by preventing colonization from pathogen species has been recently demonstrated. Moreover, recent studies underline a potential association between gut microbiota (GM) and ocular health. In this respect, some evidence supports the existence of a gut-eye axis involved in the pathogenesis of several ocular diseases, including age-related macular degeneration, uveitis, diabetic retinopathy, dry eye, and glaucoma. Therefore, understanding the link between the GM and these ocular disorders might be useful for the development of new therapeutic approaches, such as probiotics, prebiotics, symbiotics, or faecal microbiota transplantation through which the GM could be modulated, thus allowing better management of these diseases.
How does chronic stress harm the gut? New clues emerge

Max Kozlov

DOI: https://doi.org/10.1038/d41586-024-00188-4

IF: 64.8

2024-01-25

Nature

Abstract:A bacterium in the intestines of stressed mice interferes with cells that protect against pathogens. A bacterium in the intestines of stressed mice interferes with cells that protect against pathogens.

multidisciplinary sciences
The gut-eye axis: the retinal/ocular degenerative diseases and the emergent therapeutic strategies

Sonda Kammoun,Mona Rekik,Aryj Dlensi,Samir Aloulou,Walid Smaoui,Sahla Sellami,Khaled Trigui,Rahma Gargouri,Imen Chaari,Hayet Sellami,Dhawia Elatoui,Nahed Khemakhem,Ines Hadrich,Sourour Neji,Balkiss Abdelmoula,Nouha Bouayed Abdelmoula

DOI: https://doi.org/10.3389/fncel.2024.1468187

2024-10-09

Frontiers in Cellular Neuroscience

Abstract:The interplay between human microbiota and various physiological systems has garnered significant attention in recent years. The gut microbiota plays a critical role in maintaining physiological homeostasis and influences various aspects of human health, particularly via the gut brain axis. Since 2017, the challenging concept of the gut-retina axis has emerged thanks to a network analysis emphasizing the potential role of the gut microbiota disruption in the development of the age-related macular degeneration and further retinal damages. Many other ocular disorders have been linked to the dysbiosis of the gut microbiota, including uveitis and glaucoma. It has been shown that age related macular degeneration can be prevented or reversed using a diet that induces changes in the gut microbiota. The potential link between the gut microbiota as well as others types of microbiota such as the ocular surface microbiota and the development/progression of age related as well as inherited retinal degenerations and other degenerative eye diseases, has recently been broadened. Therefore, the pathogenesis of several eye diseases has recently been associated with a larger perception called the gut eye axis. This mini-review examines the potential mechanisms underlying the gut eye axis and suggests implications for the management of eye diseases. By understanding the modulation of the gut microbiota and its impact on eye disease, this mini-review provides insight into potential therapeutic interventions and avenues for future research.

neurosciences
Human gut commensals support development of ocular autoimmunity in retina-specific T cell receptor transgenic mice

Amy Zhang,Reiko Horai,Yingyos Jittayasothorn,Jonathan H. Badger,Vijayaraj Nagarajan,Caitlin Elizabeth Murphy,Wuxing Yuan,Colm O’hUigin,Kenya Honda,Rachel Caspi

DOI: https://doi.org/10.4049/jimmunol.210.supp.77.17

2023-05-01

The Journal of Immunology

Abstract:Abstract Autoimmune uveitis is a major cause of blindness, in which intraocular inflammation is driven by T cells that target the neuroretina. In a mouse model of spontaneous autoimmune uveitis (R161H), retina-specific T cells are primed in the gut through their transgenic TCR, and trigger disease. To support the relevance to human disease, we examined the development of uveitis and its association with gut microbiota in gnotobiotic R161H mice colonized with gut flora from healthy human donors. We then performed fecal metagenomic sequencing, gut immunophenotyping by flow cytometry and disease monitoring. Our results indicate that human gut commensals support development of autoimmunity in the spontaneous uveitis model. Human flora mice compared to SPF mice harboring normal mouse flora displayed altered intestinal effector and regulatory CD4 T cell profiles, and had decreased fecal metabolites including microbe-derived short chain fatty acids. Microbiome analyses showed that human flora mice retained a distinct but simplified gut microbial community compared to their original donor sample. Mice with high disease scores appeared to harbor more diverse gut flora than those with low scores. Verrucomicrobia, Actinobacteria, and Fusobacteria were enriched in mice with high disease scores, whereas Firmicutes appeared enriched in mice with low disease scores. In-vivo association studies are underway to examine the ability of candidate microbes to modulate autoimmune uveitis. These findings suggest that some taxa of human commensals may have enhancing or suppressive effects on the development of ocular autoimmunity. These candidate microbes can be explored as targets or as probiotics for therapeutic use.

immunology
Microbiome as an endocrine organ and its relationship with eye diseases: Effective factors and new targeted approaches

Leila Haghshenas,Sara Banihashemi,Yalda Malekzadegan,Roberto Catanzaro,Amir Moghadam Ahmadi,Francesco Marotta

DOI: https://doi.org/10.4291/wjgp.v15.i5.96446

2024-09-22

Abstract:Microbiome is an endocrine organ that refers to both the complicated biological system of microbial species that colonize our bodies and their genomes and surroundings. Recent studies confirm the connection between the microbiome and eye diseases, which are involved in the pathogenesis of eye diseases, including age-related macular disorders, diabetic retinopathy, glaucoma, retinitis pigmentosa, dry eye, and uveitis. The aim of this review is to investigate the microbiome in relation to eye health. First, a brief introduction of the characteristics of the gut microorganisms terms of composition and work, the role of dysbiosis, the gut microbiome and the eye microbiome in the progression of eye illnesses are highlighted, then the relationship among the microbiome and the function of the immune system and eye diseases, the role of inflammation and aging and the immune system, It has been reviewed and finally, the control and treatment goals of microbiome and eye diseases, the role of food factors and supplements, biotherapy and antibiotics in relation to microbiome and eye health have been reviewed.
The gut microbiome and primary open angle glaucoma: Evidence for a 'gut-glaucoma' axis?

Matthew Krilis,Lewis Fry,Patrick Ngo,Ivan Goldberg

DOI: https://doi.org/10.1177/11206721231219147

2023-12-14

European Journal of Ophthalmology

Abstract:European Journal of Ophthalmology, Ahead of Print. Glaucoma presents an epidemiological burden as the leading cause of irreversible blindness globally and the most common cause of preventable blindness. While elevated intraocular pressure is the strongest modifiable risk factor, the exact mechanisms of retinal ganglion cell damage leading to progressive vision loss are not entirely understood. Studies of other neurodegenerative diseases show a potential for human gut microbiome dysbiosis to play a pathogenic role. An investigation into whether the microbiome, a potential modifiable risk factor, has significance in glaucoma enables exploration of prophylactic or additive treatments. Elevated population levels of specific bacterial species have been noted in glaucoma patients, particularly Prevotellaceae, Enterobacteriaceae and Escherichia coli, while Megomonas is speculated to be protective. Evidence also points to systemic neuro-inflammation and disruption of autoimmune processes as a result of imbalances in both human and animal models, where heat shock proteins may contribute to pathogenesis. Further research into the influence of gut microbiome on pathogenesis offers a chance to minimise irreversible vision loss in glaucoma.

ophthalmology
Gut microbiota and eye diseases: a bibliometric study and visualization analysis

Xiangyu Fu,Haishan Tan,Ling Huang,Wenyue Chen,Xiang Ren,Danian Chen

DOI: https://doi.org/10.3389/fcimb.2023.1225859

2023-08-09

Abstract:Introduction: Recently the role of gut microbial dysbiosis in many ocular disorders, including but not limited to uveitis, age-related macular degeneration (AMD), diabetic retinopathy (DR), dry eye, keratitis and orbitopathy is a hot research topic in the field. Targeting gut microbiota to treat these diseases has become an unstoppable trend. Bibliometric study and visualization analysis have become essential methods for literature analysis in the medical research field. We aim to depict this area's research hotspots and future directions by bibliometric software and methods. Methods: We search all the related publications from the Web of Science Core Collection. Then, CiteSpace was applied to analyze and visualize the country distributions, dual-map overlay of journals, keyword bursts, and co-cited references. VOSviewer was employed to identify authors, co-cited authors, journals and co-cited journals and display the keyword co-occurrence networks. Results: A total of 284 relevant publications were identified from 2009 to 2023. The number of studies has been small in the first five years and has grown steadily since 2016. These studies were completed by 1,376 authors from 41 countries worldwide, with the United States in the lead. Lin P has published the most papers while Horai R is the most co-cited author. The top journal and co-cited journal are both Investigative Ophthalmology & Visual Science. In the keyword co-occurrence network, except gut microbiota, inflammation becomes the keyword with the highest frequency. Co-citation analyses reveal that gut dysbiosis is involved in common immune- and inflammation-mediated eye diseases, including uveitis, diabetic retinopathy, age-related macular degeneration, dry eye, and Graves' orbitopathy, and the study of microbiomes is no longer limited to the bacterial populations. Therapeutic strategies that target the gut microbiota, such as probiotics, healthy diet patterns, and fecal microbial transplantation, are effective and critical to future research. Conclusions: In conclusion, the bibliometric analysis displays the research hotspots and developmental directions of the involvement of gut microbiota in the pathogenesis and treatment of some ocular diseases. It provides an overview of this field's dynamic evolution and structural relationships.
Unveiling the gut-eye axis: how microbial metabolites influence ocular health and disease

Yvonne Nguyen,Josephine Rudd Zhong Manis,Nicole Marie Ronczkowski,Tommy Bui,Allston Oxenrider,Ravirajsinh N. Jadeja,Menaka C. Thounaojam

DOI: https://doi.org/10.3389/fmed.2024.1377186

IF: 3.9

2024-05-10

Frontiers in Medicine

Abstract:The intricate interplay between the gut microbiota and ocular health has surpassed conventional medical beliefs, fundamentally reshaping our understanding of organ interconnectivity. This review investigates into the intricate relationship between gut microbiota-derived metabolites and their consequential impact on ocular health and disease pathogenesis. By examining the role of specific metabolites, such as short-chain fatty acids (SCFAs) like butyrate and bile acids (BAs), herein we elucidate their significant contributions to ocular pathologies, thought-provoking the traditional belief of organ sterility, particularly in the field of ophthalmology. Highlighting the dynamic nature of the gut microbiota and its profound influence on ocular health, this review underlines the necessity of comprehending the complex workings of the gut-eye axis, an emerging field of science ready for further exploration and scrutiny. While acknowledging the therapeutic promise in manipulating the gut microbiome and its metabolites, the available literature advocates for a targeted, precise approach. Instead of broad interventions, it emphasizes the potential of exploiting specific microbiome-related metabolites as a focused strategy. This targeted approach compared to a precision tool rather than a broad-spectrum solution, aims to explore the therapeutic applications of microbiome-related metabolites in the context of various retinal diseases. By proposing a nuanced strategy targeted at specific microbial metabolites, this review suggests that addressing specific deficiencies or imbalances through microbiome-related metabolites might yield expedited and pronounced outcomes in systemic health, extending to the eye. This focused strategy holds the potential in bypassing the irregularity associated with manipulating microbes themselves, paving a more efficient pathway toward desired outcomes in optimizing gut health and its implications for retinal diseases.

medicine, general & internal
Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration

Iris Stolzer,Eveline Scherer,Patrick Süß,Veit Rothhammer,Beate Winner,Markus F Neurath,Claudia Günther

DOI: https://doi.org/10.3390/ijms241914925

2023-10-05

Abstract:The gut microbiome plays a pivotal role in maintaining human health, with numerous studies demonstrating that alterations in microbial compositions can significantly affect the development and progression of various immune-mediated diseases affecting both the digestive tract and the central nervous system (CNS). This complex interplay between the microbiota, the gut, and the CNS is referred to as the gut-brain axis. The role of the gut microbiota in the pathogenesis of neurodegenerative diseases has gained increasing attention in recent years, and evidence suggests that gut dysbiosis may contribute to disease development and progression. Clinical studies have shown alterations in the composition of the gut microbiota in multiple sclerosis patients, with a decrease in beneficial bacteria and an increase in pro-inflammatory bacteria. Furthermore, changes within the microbial community have been linked to the pathogenesis of Parkinson's disease and Alzheimer's disease. Microbiota-gut-brain communication can impact neurodegenerative diseases through various mechanisms, including the regulation of immune function, the production of microbial metabolites, as well as modulation of host-derived soluble factors. This review describes the current literature on the gut-brain axis and highlights novel communication systems that allow cross-talk between the gut microbiota and the host that might influence the pathogenesis of neuroinflammation and neurodegeneration.
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication

Esther E Fröhlich,Aitak Farzi,Raphaela Mayerhofer,Florian Reichmann,Angela Jačan,Bernhard Wagner,Erwin Zinser,Natalie Bordag,Christoph Magnes,Eleonore Fröhlich,Karl Kashofer,Gregor Gorkiewicz,Peter Holzer

DOI: https://doi.org/10.1016/j.bbi.2016.02.020

Abstract:Emerging evidence indicates that disruption of the gut microbial community (dysbiosis) impairs mental health. Germ-free mice and antibiotic-induced gut dysbiosis are two approaches to establish causality in gut microbiota-brain relationships. However, both models have limitations, as germ-free mice display alterations in blood-brain barrier and brain ultrastructure and antibiotics may act directly on the brain. We hypothesized that the concerns related to antibiotic-induced gut dysbiosis can only adequately be addressed if the effect of intragastric treatment of adult mice with multiple antibiotics on (i) gut microbial community, (ii) metabolite profile in the colon, (iii) circulating metabolites, (iv) expression of neuronal signaling molecules in distinct brain areas and (v) cognitive behavior is systematically investigated. Of the antibiotics used (ampicillin, bacitracin, meropenem, neomycin, vancomycin), ampicillin had some oral bioavailability but did not enter the brain. 16S rDNA sequencing confirmed antibiotic-induced microbial community disruption, and metabolomics revealed that gut dysbiosis was associated with depletion of bacteria-derived metabolites in the colon and alterations of lipid species and converted microbe-derived molecules in the plasma. Importantly, novel object recognition, but not spatial, memory was impaired in antibiotic-treated mice. This cognitive deficit was associated with brain region-specific changes in the expression of cognition-relevant signaling molecules, notably brain-derived neurotrophic factor, N-methyl-d-aspartate receptor subunit 2B, serotonin transporter and neuropeptide Y system. We conclude that circulating metabolites and the cerebral neuropeptide Y system play an important role in the cognitive impairment and dysregulation of cerebral signaling molecules due to antibiotic-induced gut dysbiosis.
The Microbiota-Gut-Brain Axis in Health and Disease and Its Implications for Translational Research

Melanie Anna Schächtle,Stephan Patrick Rosshart

DOI: https://doi.org/10.3389/fncel.2021.698172

2021-07-15

Frontiers in Cellular Neuroscience

Abstract:Over the past decades, microbiome research has evolved rapidly and became a hot topic in basic, preclinical and clinical research, for the pharmaceutical industry and for the general public. With the help of new high-throughput sequencing technologies tremendous progress has been made in the characterization of host-microbiota interactions identifying the microbiome as a major factor shaping mammalian physiology. This development also led to the discovery of the gut-brain axis as the crucial connection between gut microbiota and the nervous system. Consequently, a rapidly growing body of evidence emerged suggesting that the commensal gut microbiota plays a vital role in brain physiology. Moreover, it became evident that the communication along this microbiota-gut-brain axis is bidirectional and primarily mediated by biologically active microbial molecules and metabolites. Further, intestinal dysbiosis leading to changes in the bidirectional relationship between gut microbiota and the nervous system was linked to the pathogenesis of several psychiatric and neurological disorders. Here, we discuss the impact of the gut microbiota on the brain in health and disease, specifically as regards to neuronal homeostasis, development and normal aging as well as their role in neurological diseases of the highest socioeconomic burden such as Alzheimer’s disease and stroke. Subsequently, we utilize Alzheimer’s disease and stroke to examine the translational research value of current mouse models in the spotlight of microbiome research. Finally, we propose future strategies on how we could conduct translational microbiome research in the field of neuroscience that may lead to the identification of novel treatments for human diseases.

neurosciences

Daily briefing: Are gut bacteria causing eye diseases?

Gut Microbes and Eye Disease

The surprising link between gut bacteria and devastating eye diseases

Gut microbiota and eye diseases: A review

The Gut-Eye Axis: Lessons Learned from Murine Models

Daily briefing: New evidence supports controversial hypothesis of ‘transmissible’ Alzheimer’s

We are not alone: a case for the human microbiome in extra intestinal diseases

How gut microbiota may impact ocular surface homeostasis and related disorders

The gut microbiota in retinal diseases

Microbiome and Retinal Vascular Diseases

Targeting the Gut-Eye Axis: An Emerging Strategy to Face Ocular Diseases

How does chronic stress harm the gut? New clues emerge

The gut-eye axis: the retinal/ocular degenerative diseases and the emergent therapeutic strategies

Human gut commensals support development of ocular autoimmunity in retina-specific T cell receptor transgenic mice

Microbiome as an endocrine organ and its relationship with eye diseases: Effective factors and new targeted approaches

The gut microbiome and primary open angle glaucoma: Evidence for a 'gut-glaucoma' axis?

Gut microbiota and eye diseases: a bibliometric study and visualization analysis

Unveiling the gut-eye axis: how microbial metabolites influence ocular health and disease

Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration

Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication

The Microbiota-Gut-Brain Axis in Health and Disease and Its Implications for Translational Research